Skip to main content
Fig. 13 | Journal of Translational Medicine

Fig. 13

From: EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma

Fig. 13

Experimental validation of model genes. A The genes of model expression were detected by qRT-PCR. Immunohistochemistry was performed on UNCX (B), SLC6A3 (C), and PTX3 (D) in high or low CuAS group. Immunofluorescence detected the expression of VEGFA (E) and CD99 (F) in tissue samples with high and low CuAS group. G Coexpression of VEGFA and CD99 in tissue samples with high and low CuAS group. *P < 0.05, **P < 0.01, ***P < 0.001. Error bars indicate the mean ± SD

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us